Screener / SEC EDGAR /CIK 0000067887 /10-K filed Nov 26, 2025, compared with Nov 27, 2024 /Numbers from the XBRL of the 10-Ks
NYSE Industrials · Industrial Machinery

Moog Inc. MOG-A

Compare with peers Embed
SEC comment letters, last 20 years

2 reviews of MOG-A's filings by SEC staff

UPLOAD and CORRESP
Reviews 2 latest letter Feb 3, 2015
Questions asked 18 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 4 UPLOAD
  2. 2. Questions in them 18 numbered comments
  3. 3. Company replies 4 CORRESP
  4. 4. Reviews closed 2 of 2 closing letter

Half the closed reviews took 36 days or less from the first letter to the closing letter.

Form 10-K

2015-02-03 to 2015-03-09 · 2 questions · 2 letters from the SEC, 2 from the company
Review closed 2015-03-09
Goodwill and impairmentCritical estimatesResults discussion (MD&A)Liquidity and cash
Critical Accounting Policies, page 21 · Reviews for Impairment of Goodwill, page 22
SEC asked
We note that management has determined that there is current uncertainty that a material impairment charge could be recognized in the event of a reasonable change in the assumptions and estimates used to estimate the fair values of the smaller of your Aircraft Controls reporting units and the Medical Devices reporting unit.
Rest of the question

In future filings, please expand your disclosures for each reporting unit with a fair value that is not substantially in excess of the carrying value and has goodwill that is at risk for a material impairment charge to provide the following:  Identification of the reporting unit.  The amount of goodwill allocated to each reporting unit.  The fair value and carrying value of the reporting unit.  A discussion of the uncertainty associated with the specific, key assumptions for the reporting unit. An example would include assumptions in your discounted cash flow model that materially deviate from your historical results.  A discussion of any specific, potential events and/or circumstances that could have a negative effect on the estimated fair value (i.e., the specific factors to the reporting unit that management is monitoring and could result in a change to the reporting units’ estimates and/or assumptions). Please refer to Item 303 of Regulation S-K and Sections 216 and 501.14 of the Financial Reporting Codification for guidance. Please provide us with the disclosures that you would have included in your fiscal year 2014 Form 10-K in response to this comment and that you will include in your next Form 10-Q to provide investors with the expanded information on a timely basis.

MOG-A answered
For our annual test of goodwill for impairment in 2014, we determined that the fair value of our Medical Devices reporting unit exceeded its carrying value by 10%. The primary factor causing the fair value of this reporting unit to not be substantially greater than the carrying value is that the Medical Devices segment was created through a series of acquisitions between 2006 and 2009. The creation of this reporting unit resulted in recording substantial goodwill, which increased the carrying value.
Rest of the answer

Our estimated fair value is based, in part, on revenue projections of the market that our infusion therapy products serve. We expect half of our projected revenue growth to come from overall growth of the home healthcare segment of the infusion therapy market. Additionally, we expect the remaining half of our projected revenue growth to come from capturing market share due to the introduction of new technologies and the product acceptance success rates.

We are monitoring the actual growth rate of the home healthcare segment of the infusion therapy market. We are also monitoring the general economy, which affects provider capital purchase cycles, changes in healthcare legislation, changes in private insurance plans, as well as changes in treatment therapies. We are also tracking our new product development and subsequent launches, and the planned market share capture activities as well as their successes. These factors have a reasonable possibility of changing and could pose a risk to the fair value of the reporting unit and the results of our impairment review if our assumptions and estimates materially differ.

In future filings, we will expand our disclosure to provide a discussion of the specific factors that management is monitoring that have a reasonable possibility of changing and could lead to a material impairment charge to the allocated goodwill. In response to this comment, we would have provided in the Reviews for Impairment of Goodwill section of our Critical Accounting Policies in our fiscal year 2014 Form 10-K to read as follows (additional disclosures from our letter dated February 17th, 2015 are underlined).

Reviews for Impairment of Goodwill

At September 27, 2014, we had $758 million of goodwill, or 24% of total assets. We test goodwill for impairment for each of our reporting units at least annually, during our fourth quarter, and whenever events occur or circumstances change, such as changes in the business climate, poor indicators of operating performance or the sale or disposition of a significant portion of a reporting unit.

We identify our reporting units by assessing whether the components of our operating segments constitute businesses for which discrete financial information is available and segment management regularly reviews the operating results of those components. Certain of our reporting units are our operating segments while others are one level below our operating segments.

Companies may perform a qualitative assessment as the initial step in the annual goodwill impairment testing process for all or selected reporting units. Companies are also allowed to bypass the qualitative analysis and perform a quantitative analysis if desired. Economic uncertainties and the length of time from the calculation of a baseline fair value are factors that we consider in determining whether to perform a quantitative test.

When we evaluate the potential for goodwill impairment using a qualitative assessment, we consider factors including, but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for our products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel and overall financial performance. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we proceed to a quantitative two-step impairment test.

Quantitative testing first requires a comparison of the fair value of each reporting unit to its carrying value. We use the discounted cash flow method to estimate the fair value of our reporting units. The discounted cash flow method incorporates various assumptions, the most significant being projected revenue growth rates, operating margins and cash flows, the terminal growth rate and the discount rate. Management projects revenue growth rates, operating margins and cash flows based on each reporting unit's current business, expected developments and operational strategies over a five-year period. If the carrying value of the reporting unit exceeds its fair value, goodwill is considered impaired and any loss must be measured.

In measuring the impairment loss, the implied fair value of goodwill is determined by assigning a fair value to all of the reporting unit's assets and liabilities, including any unrecognized intangible assets, as if the reporting unit had been acquired in a business combination at fair value. If the carrying amount of the reporting unit goodwill exceeds the implied fair value of that goodwill, an impairment loss would be recognized in an amount equal to that excess.

Interim Test

We performed an interim test on goodwill for impairment for our Medical Devices reporting unit in the first quarter of 2014. We performed a quantitative assessment for this reporting unit, which had $85 million of goodwill as of the date of our test. Based on this test, the fair value of our Medical Devices reporting unit exceeded its carrying value by 1%. Therefore, goodwill was not impaired. The determination of each of our assumptions is subjective and requires significant estimates. Changes in these estimates and assumptions could materially affect the results of our impairment review.

Annual test - Qualitative Assessments

For our annual test of goodwill for impairment in 2014, we performed qualitative assessments for each of our three regional reporting units within Industrial Systems. We considered our most recent quantitative tests performed last year, and concluded that it is more likely than not that the fair values exceeded their carrying values.

Annual test - Quantitative Assessments

For our annual test of goodwill for impairment in 2014, we performed quantitative assessments for the other five of our reporting units. In performing these assessments, we used a 3% terminal growth rate, which is supported by our historical growth rate, near-term projections and long-term expected market growth. We then discounted our projected cash flows using weighted-average costs of capital that ranged from 10.5% to 11.0% for our various reporting units. These discount rates reflect management’s assumptions of marketplace participants’ cost of capital. Based on our tests, the fair value of each reporting unit exceeded its carrying amount. Therefore, we concluded that goodwill was not impaired.

The fair value of each reporting unit exceeded its carrying amount by at least 10%. While any individual assumption could differ from those that we used, we believe the overall fair values of our reporting units are reasonable as the values are derived from a mix of reasonable assumptions. Had we used discount rates that were 100 basis points higher than those we assumed, the fair values of the smaller of our Aircraft Controls reporting units and our Medical Devices reporting unit would not have exceeded their carrying amounts and we would have measured impairment of goodwill. However, each of our other reporting units would have still had fair values in excess of their carrying amounts by a substantial amount. If we had used a discount rate that was 50 basis points higher or a terminal growth rate that was 100 basis points lower than those we assumed, the fair values of each of our reporting units would have continued to exceed their carrying amounts.

The fair value of our Medical Devices reporting unit exceeded its carrying value by 10%, and had $85 million of associated goodwill. The primary factor causing the fair value of this reporting unit to not be substantially greater than the carrying value is that the Medical Devices segment was created through a series of acquisitions between 2006 and 2009. The creation of this reporting unit resulted in recording substantial goodwill, which increased the carrying value. The key assumptions that drive the estimated fair value are the projected revenue and operating margins, which are used to project future cash flows. Our expectation for this reporting unit is for revenue growth over the five year projection period to be driven by the overall market growth of the home healthcare segment of the infusion therapy market and by capturing market share due to new product offerings. Additionally, our expectation is that operating margins improve throughout the end of the five year projection period, which is driven by improved sales, as well as continued cost containment activities. If cash flows generated by our Medical Devices reporting unit were to decline in the future, or if there were adverse revisions to key assumptions, we may be required to record additional impairment charges. There are specific circumstances that would pose risk to the fair value of this reporting unit. Lower than projected growth rates of the home healthcare segment of the infusion therapy market, changes in provider capital purchase cycles, changes in healthcare legislation, changes in private insurance plans, as well as changes in treatment therapies may negatively affect the fair value of this reporting unit. Also, our projected market share capture rates may be lower due to delayed or unsuccessful new product offerings, which would negatively affect the fair value of this reporting unit. In addition, the fair value of this reporting unit may be negatively impacted based on the results of our strategic review and the courses of action that we may decide to pursue.

The fair value of the smaller of our Aircraft Controls reporting units exceeded its carrying value by 11%, and had $36 million of associated goodwill. The key assumptions that drive the estimated fair value are projected revenue and operating margins from long-term contract arrangements for the delivery of customer specified hardware requirements. These assumptions are used to project future cash flows. Our expectation for this reporting unit is for revenue growth over the five year projection period to be driven by broadening our product offerings, as well as continued levels of government and private sector funding. Ongoing uncertainty with respect to domestic and foreign government funding at federal and local levels, as well as private sector demand, have impacted recent operating results of this reporting unit. However, we have been able to mitigate the impacts with cost reduction initiatives. The circumstances that would pose risk to the fair value of this reporting unit include projected revenue not materializing due to the loss of key contracts, delayed or cancelled new product offerings and delayed funding, as well as potential increases in our cost infrastructure. If cash flows generated by this reporting unit were to decline in the future, or if there were negative revisions to key assumptions, we may be required to record an impairment charge.

With the exception of these two reporting units, each of our other reporting units exceeded their carrying values by at least 69%.

We evaluate the reasonableness of the resulting fair values of our reporting units by comparing the aggregate fair value to our market capitalization and assessing the reasonableness of any resulting premium.

The determination of our assumptions is subjective and requires significant estimates. Changes in these estimates and assumptions could materially affect the results of our reviews for impairment of goodwill.

Additionally, in our next Form 10-Q, we will include this same, complete disclosure in our Critical Accounting Policies section to provide investors with this expanded information on a timely basis.

We acknowledge that:

•

Moog is responsible for the adequacy and accuracy of the disclosure in the filings;

Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

Moog may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We believe that our responses adequately address the comments in your letter. If you have any questions or require any additional information, please contact me at (716) 652-2000.

Read in the reply
In its next report

First report after the company's reply of Mar 6, 2015: 10-Q filed May 4, 2015 ↗, against the 10-Q filed Feb 3, 2015 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

SEC letter of Feb 23, 2015 ↗ no reply letter on EDGAR
Critical Accounting Policies, page 21 · Reviews for Impairment of Goodwill, page 22
SEC asked
We note the draft disclosures you provided in response to the comment in our letter dated February 3, 2015. Please expand the analysis provided for the Medical Devices reporting unit to provide the specific factors that are causing the fair value of this reporting unit to not be substantially in excess of the carrying value.
Rest of the question

Please also provide an analysis of the specific factors that management is monitoring that have the reasonable possibility of changing and could lead to a material impairment charge to the allocated goodwill. In this regard, your statement, “[t]he circumstances that would pose risk to the fair value of this reporting unit include lower than projected sales growth due to the delay of new product offerings, reduced market share or lower industry growth, as well as potential increases in our cost infrastructure” does not appear to be specific to the Medical Devices reporting unit. Please provide us with the additional revisions you intend to include in your next periodic report.

MOG-A answered

No reply letter found.

In its next report

First report after the SEC's letter of Feb 23, 2015: 10-Q filed May 4, 2015 ↗, against the 10-Q filed Feb 3, 2015 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: company letter, Feb 17, 2015, closing letter, 2015-03-09

Form 10-K

2014-04-01 to 2014-05-07 · 16 questions · 2 letters from the SEC, 2 from the company
Review closed 2014-05-07
Results discussion (MD&A)Liquidity and cashSegmentsPensionsInventoryGoodwill and impairmentIncome taxesLegal and contingenciesReserves and insuranceAcquisitionsDebtRevenueControls
Operations, page 19 · Reserves for Inventory Valuation, page 21
SEC asked (1)
We note that the reserves for inventory valuation were reduced by $15.7 million during fiscal year 2013 for the write-off and sale of obsolete inventory. We further note that the total amount of reserves for inventory valuation is approximately six times this amount with similar and/or greater trends for fiscal years 2012 and 2011.
Rest of the question

Please provide us with a comprehensive explanation as to why your reserve balance is so much greater than the amounts being written off during the periods. As part of your response, please quantify the amount of inventory as of September 28, 2013, that is comprised of products that either had no sales during fiscal year 2013 or are considered by management to be slow-moving. Further, please expand your disclosure in future filings to identify the specific risk elements that management observed in the inventory portfolio.

MOG-A answered
We have reviewed your April 21, 2014 letter regarding your comments on the above-referenced SEC filings. For your convenience, we have included the Staff’s comments in italics before each of our responses. Form 10-K for Fiscal Year Ended September 28, 2013 Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, page 19 Reviews for Impairment of Goodwill, page 22 We note your response to comment 2 in our letter dated April 1, 2014.
Rest of the letter

It remains unclear how you determined that the disclosures you provided on page 23 of your fiscal year 2013 Form 10-K provide investors with an understanding of the risks and uncertainties that could result in a material impairment charge for the remaining Medical Devices reporting unit’s goodwill of $85.2 million. As such, we continue to request that you expand your disclosure in future filings to provide a discussion of the uncertainty associated with the specific, key assumptions included in the discounted cash flow method used to estimate the fair value that will allow an investor to understand the risks through the eyes of management, or disclose that there is no material uncertainty associated with the remaining goodwill balance for this reporting unit. If you believe you have provided this disclosure elsewhere in the Form 10- K, please provide us with the specific location of this disclosure and confirm to us that you will provide a cross-reference to this disclosure in future filings. Please refer to Item 303 of Regulation S-K and Sections 216 and 501.14 of the Financial Reporting Codification for guidance. In future filings, we will expand our disclosure to provide a discussion of the uncertainty associated with the specific, key assumptions included in the discounted cash flow method used to estimate the fair value that will allow an investor to understand the risks through the eyes of management, or disclose that there is no material uncertainty associated with the remaining goodwill balance for this reporting unit. Consolidated Results of Operations, page 25 We note your response to comment 4 in our letter dated April 1, 2014. While we understand that you have provided investors with insight into management’s expectations for 2014, the disclosure does not reference the impact of the restructuring plans to future operating results. As such, it remains unclear how this referenced disclosure addresses the requirements in SAB Topic 5:P.4. As previously requested, please confirm to us that you will provide disclosure of the anticipated future cost savings at the consolidated and reportable segment levels, and whether the actual results are in line with the anticipated cost savings in future filings. If the anticipated savings were not achieved as expected or are achieved in periods other than as expected, please disclose as such, the reasons for the differences, and the likely effects on future operating results and liquidity. As previously noted, the restructuring plans during fiscal year 2013 negatively impacted earnings before income taxes by 8.5%. In future filings, we will provide disclosure of the anticipated future cost savings at the consolidated and reportable segment levels, and whether the actual results are in line with the anticipated cost savings. We will also disclose if the anticipated savings were not achieved as expected or are achieved in periods other than as expected, the reasons for the differences and the likely effects on future operating results and liquidity. Moog is responsible for the adequacy and accuracy of the disclosure in the filings; Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and Moog may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We believe that our responses adequately address the comments in your letter. If you have any questions or require any additional information, please contact me at (716) 652-2000.

One letter for all the questions, without numbered answers. Read the reply
In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Reviews for Impairment of Goodwill, page 22
SEC asked (2)
Please expand your discussion of the Medical Devices reporting unit to provide a discussion of the uncertainty associated with the specific, key assumptions that will allow an investor to understand the risks through the eyes of management.
Rest of the question

Examples would include assumptions in your discounted cash flow model that materially deviate from your historical results and quantified information regarding potential outcomes of divesting the business, where useful and available. Also, discuss the specific, potential events or circumstances surrounding the ongoing business, as well as potential divestiture outcomes that could have a negative effect on the estimated fair value. Please refer to Item 303 of Regulation S-K and Sections 216 and 501.14 of the Financial Reporting Codification for guidance.

MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Consolidated Results of Operations, page 25
SEC asked (3)
In future filings, please quantify the impact of the factors disclosed as materially impacting the line items comprising income from continuing operations for each period presented at the consolidated level and the segment level.
Rest of the question

One example is your discussion and analysis of consolidated gross profit in which you identify a favorable change in product mix for three of your reportable segments offset by charges from recent acquisitions without quantifying the impact of each of these factors. Please refer to Items 303(a)(3)(i), 303(a)(3)(iii), and 303(a)(3)(iv) of Regulation S-X and Section 501.12.b.3 of the Financial Reporting Codification for guidance.

MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Consolidated Results of Operations, page 25
SEC asked (4)
We note that you initiated restructuring plans during fiscal year 2013 that were 8.5% of earnings before income taxes. We further note that you intend to focus on cost reductions during fiscal year 2014 in light of your weaker than planned first quarter of fiscal year 2014 operating results.
Rest of the question

In future filings, please disclose the anticipated future cost savings at the consolidated and reportable segment levels, and whether the actual results are in line with the anticipated cost savings. If the anticipated savings were not achieved as expected or are achieved in periods other than as expected, please disclose as such, the reasons for the differences, and the likely effects on future operating results and liquidity. Please refer to SAB Topic 5:P.4 and ASC 420-10-50-1 for guidance.

MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Consolidated Results of Operations, page 25
SEC asked (5)
We note that your total pension expense increased 42.5% for fiscal year 2013 as compared to fiscal year 2012. However, you did not provide investors with an understanding as to why. In future filings, please ensure that you provide investors with an analysis of the material factors impacting the components of income from continuing operations.
Rest of the question

For pension expense specifically, you could refer to the discussion of assumptions on page 23, and analyze how the changes in assumptions affected the specific financial statement line items in the reported periods. Please refer to Item 303(a)(3) of Regulation S-K and Section 501.12.b.4. of the Financial Reporting Codification for guidance.

MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Consolidated Results of Operations, page 25
SEC asked (6)
We note that the retirement liability adjustment within other comprehensive income has materially impacted total comprehensive income for each period presented. Please expand your disclosures in future filings to provide a comprehensive discussion and analysis of how the changes in the material assumptions impacting pension expense (e.g., discount rate, expected long-term rate of return on plan assets, and expected
Rest of the question

rate of compensation increase) led to the adjustments recognized.

MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Capital Structure and Resources, page 35
SEC asked (7)
In future filings, please clarify that the $496 million of unused borrowing capacity is available without violating any debt covenants, if correct.
MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Contractual Obligations and Commercial Commitments, page 36
SEC asked (8)
We note that you significantly increased your pension contributions for fiscal year 2013 above the minimum funding requirement and that you anticipate doing the same for fiscal year 2014. In future filings, please explain the factors that contributed to this cash management decision along with the impact to your consolidated financial statements.
MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 1 – Summary of Significant Accounting Policies, page 45 · Revenue Recognition, page 45
SEC asked (9)
In future filings, please disclose the percentage of revenue recognized using percentage of completion, cost-to-cost method of accounting for all periods presented rather than the most recent period only. Please also address this in Note 17 – Segments for Aircraft Controls.
MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 4 – Inventories, page 50
SEC asked (10)
In future filings, please provide the disclosures required by Article 5-02.6(d) of Regulation S- X, or clarify that inventories related to long-term contracts is immaterial.
MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 18 – Commitments and Contingencies, page 75
SEC asked (11)
In future filings, please revise your disclosure to state if the legal proceedings and/or environmental matters are expected to be material to your cash flows in addition to your financial condition and results of operations.
Rest of the question

Also, if there is at least a reasonable possibility that a loss exceeding amounts already recognized may have been incurred, please either disclose an estimate (or, if true, state that the estimate is immaterial in lieu of providing quantified amounts) of the additional loss or range of loss, or state that such an estimate cannot be made. Please refer to ASC 450-20-50.

MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Management’s Report on Internal Control over Financial Reporting, page 77
SEC asked (12)
Please revise future filings to clarify which version, 1992 or 2013, of the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control — Integrated Framework you utilized when performing your assessment of internal control over financial reporting.
MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

General
SEC asked (13)
In future filings, please include disclosures for your loss contingencies in accordance with the guidance in ASC 450-20-50. Please refer to Article 10-01(a)(5) of Regulation S-X for guidance.
MOG-A answered

See the reply above.

Note 3 – Receivables, page 7
SEC asked (14)
In future filings, please provide the disaggregated disclosures for receivables per Article 502.3(c) of Regulation S-X in light of the significance to total current assets and your liquidity.
MOG-A answered

See the reply above.

In its next report

First report after the company's reply of Apr 28, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

SEC letter of Apr 21, 2014 ↗ no reply letter on EDGAR
Operations, page 19 · Reviews for Impairment of Goodwill, page 22
SEC asked (1)
We note your response to comment 2 in our letter dated April 1, 2014. It remains unclear how you determined that the disclosures you provided on page 23 of your fiscal year 2013 Form 10-K provide investors with an understanding of the risks and uncertainties that could result in a material impairment charge for the remaining Medical Devices reporting unit’s goodwill of $85.2 million.
Rest of the question

As such, we continue to request that you expand your disclosure in future filings to provide a discussion of the uncertainty associated with the specific, key assumptions included in the discounted cash flow method used to estimate the fair value that will allow an investor to understand the risks through the eyes of management, or disclose that there is no material uncertainty associated with the remaining goodwill balance for this reporting unit. If you believe you have provided this disclosure elsewhere in the Form 10-K, please provide us with the specific location of this disclosure and confirm to us that you will provide a cross-reference to this disclosure in future filings. Please refer to Item 303 of Regulation S-K and Sections 216 and 501.14 of the Financial Reporting Codification for guidance.

MOG-A answered

No reply letter found.

In its next report

First report after the SEC's letter of Apr 21, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Consolidated Results of Operations, page 25
SEC asked (2)
We note your response to comment 4 in our letter dated April 1, 2014. While we understand that you have provided investors with insight into management’s expectations for 2014, the disclosure does not reference the impact of the restructuring plans to future operating results. As such, it remains unclear how this referenced disclosure addresses the requirements in SAB Topic 5:P.4.
Rest of the question

As previously requested, please confirm to us that you will provide disclosure of the anticipated future cost savings at the consolidated and reportable segment levels, and whether the actual results are in line with the anticipated cost savings in future filings. If the anticipated savings were not achieved as expected or are achieved in periods other than as expected, please disclose as such, the reasons for the differences, and the likely effects on future operating results and liquidity. As previously noted, the restructuring plans during fiscal year 2013 negatively impacted earnings before income taxes by 8.5%.

MOG-A answered

No reply letter found.

In its next report

First report after the SEC's letter of Apr 21, 2014: 10-Q filed Apr 30, 2014 ↗, against the 10-Q filed Jan 29, 2014 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: company letter, Apr 15, 2014, closing letter, 2014-05-07

SEC enforcement releases naming MOG-A

Litigation releases and accounting and auditing enforcement releases (AAER) · sec.gov

1

A release is listed only when SEC's list names MOOG INC. (or a name it had before) among those the action is against. The page does not say what the release found: open it on sec.gov. A release against a person at the company, or one that names the company under another spelling, is not matched, so this list can be shorter than SEC's.

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 10 letters filed since 2014-04-01. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MOG-A/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.